, China
670 views
/Ryoji Iwata from Unsplash

Foreign insurance brokers enter China market: Report

These are the first foreign-funded companies approved in the sector since 2018.

Two foreign-owned insurance brokerage companies, BMW (China) Insurance Brokers and ERGO-FESCO Broker Company, have obtained permits to conduct insurance brokerage business in China, marking a significant step in the country's financial opening up, Xinhua News Agency reported. 

These are the first foreign-funded companies approved in the sector since 2018, according to the National Financial Regulatory Administration (NFRA).

READ MORE: Foreign-funded companies upbeat about China's insurance brokerage business

The companies have been granted authorisation to engage in insurance brokerage activities, including developing insurance plans for policyholders and reinsurance brokerage, within the Chinese mainland. 

ALSO READ: China’s insurance sector sees steady Q3 growth in assets

The company plans to accelerate business expansion in 2024, supporting the BMW Group's transformation toward electrification, digitization, and circular sustainability.

ERGO-FESCO, co-established by ERGO (a major insurance company in Germany and Europe) and Beijing Foreign Enterprise Human Resources Service, sees China as a key strategic investment market. 

 

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.